Completed
Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study
What is being tested
UV Light Treatment
Device
Who is being recruted
Coronaviridae Infections+3
+ Infections
+ RNA Virus Infections
Over 18 Years
+6 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Study Start: October 2020
Summary
Principal SponsorCedars-Sinai Medical Center
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: October 30, 2020
Actual date on which the first participant was enrolled.This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.
Official TitleRespiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study
Principal SponsorCedars-Sinai Medical Center
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
5 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Coronaviridae InfectionsInfectionsRNA Virus InfectionsVirus DiseasesCoronavirus InfectionsNidovirales Infections
Criteria
3 inclusion criteria required to participate
Confirmed positive test result for SARS-CoV-2
Mechanically ventilated
Endotracheal tube inner diameter of at least 7.5 mm
3 exclusion criteria prevent from participating
Unable to provide informed consent (or surrogate)
Enrolled in a therapeutic clinical trial for same condition that does not allow recruitment in other trials
Pregnant women
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalMechanically ventilated patients who will receive UV Light therapy
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
Cedars-Sinai Medical Center
Los Angeles, United StatesOpen Cedars-Sinai Medical Center in Google MapsCompletedOne Study Center